期刊文献+

门静脉微癌栓和肉眼癌栓对肝癌患者术后生存的影响 被引量:44

The effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma
原文传递
导出
摘要 目的 评价肝癌门静脉微癌栓和肉眼癌栓对术后生存的影响。方法 回顾性分析3348例肝癌切除术患者的临床资料,分为门静脉无癌栓组(n=2528)、微癌栓组(n=416)和肉眼癌栓组(n=404),单因素分析肝癌门静脉微癌栓和肉眼癌栓对术后生存的影响,分析各组的生存率。结果 单因素分析肝癌门静脉微癌栓和门静脉肉眼癌栓对术后生存影响的危险度分别为1 421和3 136;无癌栓组的1、3、5、10年累积生存率分别为85. 97%、62 .78%、49 .88%、35 .42%,中位生存时间为59 7个月;微癌栓组的1、3、5、10年累积生存率分别为74 .42%、51. 66%、39 .25%、27 .28%,中位生存时间为39 .1个月; 肉眼癌栓组的1、3、5、10年累积生存率分别为52 59%、25. 97%、20 .42%、11 .33%,中位生存时间为13. 5个月。结论 门静脉癌栓是影响肝癌患者术后生存的重要因素,而肉眼癌栓的危险性远大于微癌栓;微癌栓阶段是影响术后生存的转折点。 Objective To evaluate the effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients with hepatocellular carcinoma (HCC).Methods Three thousand three hundred and forty eight HCC patients were retrospectively reviewed, which were divided into no portal vein tumor thrombi (PVTT), microscopic PVTT and macroscopic PVTT groups according to the pathology, effects of portal vein microscopic and macroscopic tumor thrombi on post-operation patients′s survival were studied by univariate analysis and overall survival was evaluated in each group.Results Hazard ratio(HR) of portal vein microscopic tumor thrombi and macroscopic tumor thrombi was 1.421 and 3.136 respectively; The overall 1-,3-,5- and 10-year cumulative survival rate was 85.97%,62.78%,49.88% and 35.42% respectively, and mean time for survival was 59.7 months in group without PVTT, while 74.42%,51.66%,39.25% and 27.28% respectively and mean time for survival 39.1 months in group with microscopic PVTT, 52.59%,25.97%,20.42% and 11.33% respectively and mean time for survival 13.5 months in group with macroscopic PVTT.Conclusions PVTT was an important prognostic factor for survival in post-operation patients with HCC while macroscopic PVTT was more danger than microscopic PVTT. The period of microscopic PVTT was the landmark affecting post-operation survival.
出处 《中华外科杂志》 CAS CSCD 北大核心 2005年第7期433-435,共3页 Chinese Journal of Surgery
基金 上海百人计划基金资助项目(97BR029) 上海科技发展基金资助项目(984419067)
关键词 门静脉微癌栓 肉眼癌栓 肝癌 术后 生存质量 肿瘤细胞 Carcinoma, hepatocellular Portal vein Hepatectomy Treatment outcome Tumor thrombi
  • 相关文献

参考文献6

  • 1樊嘉,吴志全,周俭,邱双健,汤钊猷,余业勤,张博恒.肝细胞癌伴门静脉癌栓不同治疗方法的比较[J].中华肿瘤杂志,2000,22(3):247-249. 被引量:72
  • 2Yamada K, Izaki K, Sugimoto K, et al. Prospective trial of combined transcatheter arterial chemoembolization and three-dimensional conformal radiotherapy for portal vein tumor thrombus in patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys, 2003,57:113-119.
  • 3Cedrone A, Rapaccini GL, Pompili M,et al. Portal vein thrombosis complicating hepatocellular carcinoma. Value of ultrasound-guided fine-needle biopsy of the thrombus in the therapeutic management.Liver, 1996,16:94-98.
  • 4Fong Y, Sun RL, Jarnagin W, et al. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg, 1999,229:790-799.
  • 5Giannelli G, Pierri F, Trerotoli P, et al. Occurrence of portal vein tumor thrombus in hepatocellular carcinoma affects prognosis and survival. A retrospective clinical study of 150 cases. Hepatol Res,2002,24:50-59.
  • 6Ohkubo T, Yamamoto J, Sugawara Y, et al. Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg, 2000, 191:657-660.

二级参考文献3

  • 1Masao Mitsunobu,Akihiro Toyosaka,Takeshi Oriyama,Eizo Okamoto,Norio Nakao. Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vessel[J] 1996,Clinical & Experimental Metastasis(6):520~529
  • 2Tetsuya Katsumori M.D.,Masato Fujita,Takeshi Takahashi,Osamu Satoh,Shigeki Ichijima,Toshiyuki Nakamura,Hiroyuki Morishita,Kohji Ohno,Yasuhiko Nakano,Tomoho Maeda. Effective segmental chemoembolization of advanced hepatocellular carcinoma with tumor thrombus in the portal vein[J] 1995,CardioVascular and Interventional Radiology(4):217~221
  • 3Yoshio Yamaoka M.D.,Kaoru Kumada M.D.,Keiichi Ino M.D.,Takashi Takayasu M.D.,Yasuyuki Shimahara M.D.,Keiichiro Mori M.D.,Akira Tanaka M.D.,Taisuke Morimoto M.D.,Yoshiro Taki M.D.,Masanobu Washida M.D.,Dai Manaka M.D.,Michihiro Hayashi M.D.,Takusi Fujita M.D.,Kazue Ozawa M.D.. Liver resection for hepatocellular carcinoma (HCC) with direct removal of tumor thrombi in the main portal vein[J] 1992,World Journal of Surgery(6):1172~1176

共引文献71

同被引文献377

引证文献44

二级引证文献382

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部